miR-137 alleviates doxorubicin resistance in breast cancer through inhibition of epithelial-mesenchymal transition by targeting DUSP4

Acquired resistance to chemotherapy is a major obstacle in breast cancer (BC) treatment. Accumulated evidence has uncovered that microRNAs (miRNAs) are vital regulators of chemoresistance in cancer. Growing studies reveal that miR-137 acts as a suppressor in tumor progression. However, it remains ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Feiya, Yu, Ling, Wu, Ying, Wang, Shuqian, Yao, Jia, Zheng, Xiaoxiao, Xie, Shangzhi, Zhang, Shufeng, Lu, Xuemei, Liu, Yu, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892819/
https://www.ncbi.nlm.nih.gov/pubmed/31801953
http://dx.doi.org/10.1038/s41419-019-2164-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892819/
https://www.ncbi.nlm.nih.gov/pubmed/31801953
http://dx.doi.org/10.1038/s41419-019-2164-2

Ejemplares similares